Skip to main content
Erschienen in: Journal of Neurology 2/2019

04.12.2018 | Original Communication

ANO10 mutational screening in recessive ataxia: genetic findings and refinement of the clinical phenotype

verfasst von: Lorenzo Nanetti, Elisa Sarto, Anna Castaldo, Stefania Magri, Alessia Mongelli, Davide Rossi Sebastiano, Laura Canafoglia, Marina Grisoli, Chiara Malaguti, Francesca Rivieri, Maria Chiara D’Amico, Daniela Di Bella, Silvana Franceschetti, Caterina Mariotti, Franco Taroni

Erschienen in: Journal of Neurology | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Autosomal recessive cerebellar ataxia type 3 (ARCA3) is a rare inherited disorder caused by mutations in the ANO10 gene. The disease is characterized by slowly progressive spastic ataxia variably associated with motor neuron involvement, epilepsy, and cognitive decline. We performed mutational screening in 80 patients with sporadic or autosomal recessive adult-onset ataxia. We identified 11 ANO10 gene variants in 10 patients from 8 families (10%): 4 mutations were previously described and 7 were novel. Age at onset ranged between 27 and 53 years. All patients presented ataxia, pyramidal signs and cerebellar atrophy at brain MRI. Additional signs were bradykinesia (7/10), mild vertical gaze paresis (5/10), pes cavus (4/10), and sphincteric disturbances (3/10). Six patients, with normal MMSE score, failed several neuropsychological tests rating executive functions. Three patients had giant somatosensory evoked potentials and epileptic spikes in EEG without clinical evidence of seizures. Our observational study indicates a high frequency of ARCA3 disease in sporadic patients with adult-onset cerebellar ataxia. We extended the ANO10 mutational spectrum with the identification of novel gene variants, and further defined the clinical, cognitive, and neurophysiological features in a new cohort of patients. These findings may contribute to the refinement of the complex ARCA3 phenotype and be valuable in clinical management and natural history studies.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Parodi L, Coarelli G, Stevanin G, Brice A, Durr A (2018) Hereditary ataxias and paraparesias: clinical and genetic update. Curr Opin Neurol 31:462–471PubMed Parodi L, Coarelli G, Stevanin G, Brice A, Durr A (2018) Hereditary ataxias and paraparesias: clinical and genetic update. Curr Opin Neurol 31:462–471PubMed
2.
Zurück zum Zitat Beaudin M, Klein CJ, Rouleau GA, Dupré N (2017) Systematic review of autosomal recessive ataxias and proposal for a classification. Cerebellum Ataxias 4:3CrossRefPubMedPubMedCentral Beaudin M, Klein CJ, Rouleau GA, Dupré N (2017) Systematic review of autosomal recessive ataxias and proposal for a classification. Cerebellum Ataxias 4:3CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Vermeer S, Hoischen A, Meijer RP et al (2010) Targeted next-generation sequencing of a 12.5 Mb homozygous region reveals ANO10 mutations in patients with autosomal-recessive cerebellar ataxia. Am J Hum Genet 87:813–819CrossRefPubMedPubMedCentral Vermeer S, Hoischen A, Meijer RP et al (2010) Targeted next-generation sequencing of a 12.5 Mb homozygous region reveals ANO10 mutations in patients with autosomal-recessive cerebellar ataxia. Am J Hum Genet 87:813–819CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Renaud M, Anheim M, Kamsteeg EJ et al (2014) Autosomal recessive cerebellar ataxia type 3 due to ANO10 mutations: delineation and genotype-phenotype correlation study. JAMA Neurol 71:1305–1310CrossRefPubMed Renaud M, Anheim M, Kamsteeg EJ et al (2014) Autosomal recessive cerebellar ataxia type 3 due to ANO10 mutations: delineation and genotype-phenotype correlation study. JAMA Neurol 71:1305–1310CrossRefPubMed
6.
Zurück zum Zitat Fogel BL, Lee H, Deignan JL et al (2014) Exome sequencing in the clinical diagnosis of sporadic or familial cerebellar ataxia. JAMA Neurol 71:1237–1246CrossRefPubMedPubMedCentral Fogel BL, Lee H, Deignan JL et al (2014) Exome sequencing in the clinical diagnosis of sporadic or familial cerebellar ataxia. JAMA Neurol 71:1237–1246CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Chamova T, Florez L, Guergueltcheva V et al (2012) ANO10 c.1150_1151del is a founder mutation causing autosomal recessive cerebellar ataxia in Roma/Gypsies. J Neurol 259:906–911CrossRefPubMed Chamova T, Florez L, Guergueltcheva V et al (2012) ANO10 c.1150_1151del is a founder mutation causing autosomal recessive cerebellar ataxia in Roma/Gypsies. J Neurol 259:906–911CrossRefPubMed
8.
Zurück zum Zitat Maruyama H, Morino H, Miyamoto R, Murakami N, Hamano T, Kawakami H (2014) Exome sequencing reveals a novel ANO10 mutation in a Japanese patient with autosomal recessive spinocerebellar ataxia. Clin Genet 85:296–297CrossRefPubMed Maruyama H, Morino H, Miyamoto R, Murakami N, Hamano T, Kawakami H (2014) Exome sequencing reveals a novel ANO10 mutation in a Japanese patient with autosomal recessive spinocerebellar ataxia. Clin Genet 85:296–297CrossRefPubMed
9.
Zurück zum Zitat Yoshida K, Miyatake S, Kinoshita T et al (2014) ‘Cortical cerebellar atrophy’ dwindles away in the era of next-generation sequencing. J Hum Genet 59:589–590CrossRefPubMedPubMedCentral Yoshida K, Miyatake S, Kinoshita T et al (2014) ‘Cortical cerebellar atrophy’ dwindles away in the era of next-generation sequencing. J Hum Genet 59:589–590CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Minnerop M, Bauer P (2015) Autosomal recessive cerebellar ataxia 3 due to homozygote c.132dupA mutation within the ANO10 gene. JAMA Neurol 72:238–239CrossRefPubMed Minnerop M, Bauer P (2015) Autosomal recessive cerebellar ataxia 3 due to homozygote c.132dupA mutation within the ANO10 gene. JAMA Neurol 72:238–239CrossRefPubMed
11.
Zurück zum Zitat Chamard L, Sylvestre G, Koenig M, Magnin E (2016) Executive and attentional disorders, epilepsy and porencephalic cyst in autosomal recessive cerebellar ataxia type 3 due to ANO10 mutation. Eur Neurol 75:186–190CrossRefPubMed Chamard L, Sylvestre G, Koenig M, Magnin E (2016) Executive and attentional disorders, epilepsy and porencephalic cyst in autosomal recessive cerebellar ataxia type 3 due to ANO10 mutation. Eur Neurol 75:186–190CrossRefPubMed
12.
Zurück zum Zitat Mišković ND, Domingo A, Dobričić V et al (2016) Seemingly dominant inheritance of a recessive ANO10 mutation in romani families with cerebellar ataxia. Mov Disord 31:1929–1931CrossRefPubMed Mišković ND, Domingo A, Dobričić V et al (2016) Seemingly dominant inheritance of a recessive ANO10 mutation in romani families with cerebellar ataxia. Mov Disord 31:1929–1931CrossRefPubMed
13.
Zurück zum Zitat Bodranghien F, Oulad Ben Taib N, Van Maldergem L, Manto M (2017) A postural tremor highly responsive to transcranial cerebello-cerebral DCS in ARCA3. Front Neurol 8:71CrossRefPubMedPubMedCentral Bodranghien F, Oulad Ben Taib N, Van Maldergem L, Manto M (2017) A postural tremor highly responsive to transcranial cerebello-cerebral DCS in ARCA3. Front Neurol 8:71CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Coutelier M, Hammer MB, Stevanin G et al (2018) Efficacy of exome-targeted capture sequencing to detect mutations in known cerebellar ataxia genes. JAMA Neurol 75:591–599CrossRefPubMedPubMedCentral Coutelier M, Hammer MB, Stevanin G et al (2018) Efficacy of exome-targeted capture sequencing to detect mutations in known cerebellar ataxia genes. JAMA Neurol 75:591–599CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405–424CrossRefPubMedPubMedCentral Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405–424CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Halliday DM, Rosenberg JR, Amjad AM, Breeze P, Conway BA, Farmer SF (1995) A framework for the analysis of mixed time series/point process data—theory and application to the study of physiological tremor, single motor unit discharges and electromyograms. Prog Biophys Mol Biol 64:237–278CrossRefPubMed Halliday DM, Rosenberg JR, Amjad AM, Breeze P, Conway BA, Farmer SF (1995) A framework for the analysis of mixed time series/point process data—theory and application to the study of physiological tremor, single motor unit discharges and electromyograms. Prog Biophys Mol Biol 64:237–278CrossRefPubMed
18.
Zurück zum Zitat Panzica F, Canafoglia L, Franceschetti S et al (2003) Movement-activated myoclonus in genetically defined progressive myoclonic epilepsies: EEG-EMG relationship estimated using autoregressive models. Clin Neurophysiol 114:1041–1052CrossRefPubMed Panzica F, Canafoglia L, Franceschetti S et al (2003) Movement-activated myoclonus in genetically defined progressive myoclonic epilepsies: EEG-EMG relationship estimated using autoregressive models. Clin Neurophysiol 114:1041–1052CrossRefPubMed
19.
Zurück zum Zitat Mochizuki H, Hanajima R, Kowa H et al (2001) Somatosensory evoked potential recovery in myotonic dystrophy. Clin Neurophysiol 112:793–799CrossRefPubMed Mochizuki H, Hanajima R, Kowa H et al (2001) Somatosensory evoked potential recovery in myotonic dystrophy. Clin Neurophysiol 112:793–799CrossRefPubMed
20.
Zurück zum Zitat Visani E, Canafoglia L, Rossi Sebastiano D et al (2013) Giant SEPs and SEP-recovery function in Unverricht–Lundborg disease. Clin Neurophysiol 124:1013–1018CrossRefPubMed Visani E, Canafoglia L, Rossi Sebastiano D et al (2013) Giant SEPs and SEP-recovery function in Unverricht–Lundborg disease. Clin Neurophysiol 124:1013–1018CrossRefPubMed
21.
Zurück zum Zitat Synofzik M, Smets K, Mallaret M et al (2016) SYNE1 ataxia is a common recessive ataxia with major non-cerebellar features: a large multi-centre study. Brain 139:1378–1393CrossRefPubMedPubMedCentral Synofzik M, Smets K, Mallaret M et al (2016) SYNE1 ataxia is a common recessive ataxia with major non-cerebellar features: a large multi-centre study. Brain 139:1378–1393CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Schmahmann JD, Sherman JC (1998) The cerebellar cognitive affective syndrome. Brain 121:561–579CrossRefPubMed Schmahmann JD, Sherman JC (1998) The cerebellar cognitive affective syndrome. Brain 121:561–579CrossRefPubMed
24.
Zurück zum Zitat Saccà F, Costabile T, Abate F et al (2017) Normalization of timed neuropsychological tests with the PATA rate and nine-hole pegboard tests. J Neuropsychol 12:471–483CrossRefPubMed Saccà F, Costabile T, Abate F et al (2017) Normalization of timed neuropsychological tests with the PATA rate and nine-hole pegboard tests. J Neuropsychol 12:471–483CrossRefPubMed
25.
Zurück zum Zitat Martín-Palomeque G, Castro-Ortiz A, Pamplona-Valenzuela P, Saiz-Sepúlveda M, Cabañes-Martínez L, López JR (2017) Large amplitude cortical evoked potentials in nonepileptic patients. Reviving an old neurophysiologic tool to help detect CNS pathology. J Clin Neurophysiol 34:84–91CrossRefPubMed Martín-Palomeque G, Castro-Ortiz A, Pamplona-Valenzuela P, Saiz-Sepúlveda M, Cabañes-Martínez L, López JR (2017) Large amplitude cortical evoked potentials in nonepileptic patients. Reviving an old neurophysiologic tool to help detect CNS pathology. J Clin Neurophysiol 34:84–91CrossRefPubMed
26.
Zurück zum Zitat Miwa H, Mizuno Y (2002) Enlargements of somatosensory-evoked potentials in progressive supranuclear palsy. Acta Neurol Scand 106:209–212CrossRefPubMed Miwa H, Mizuno Y (2002) Enlargements of somatosensory-evoked potentials in progressive supranuclear palsy. Acta Neurol Scand 106:209–212CrossRefPubMed
27.
Zurück zum Zitat Shimizu T, Bokuda K, Kimura H et al (2018) Sensory cortex hyperexcitability predicts short survival in amyotrophic lateral sclerosis. Neurology 90:1578–1587CrossRef Shimizu T, Bokuda K, Kimura H et al (2018) Sensory cortex hyperexcitability predicts short survival in amyotrophic lateral sclerosis. Neurology 90:1578–1587CrossRef
Metadaten
Titel
ANO10 mutational screening in recessive ataxia: genetic findings and refinement of the clinical phenotype
verfasst von
Lorenzo Nanetti
Elisa Sarto
Anna Castaldo
Stefania Magri
Alessia Mongelli
Davide Rossi Sebastiano
Laura Canafoglia
Marina Grisoli
Chiara Malaguti
Francesca Rivieri
Maria Chiara D’Amico
Daniela Di Bella
Silvana Franceschetti
Caterina Mariotti
Franco Taroni
Publikationsdatum
04.12.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 2/2019
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-018-9141-z

Weitere Artikel der Ausgabe 2/2019

Journal of Neurology 2/2019 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.